Five Things For Pharmacists To Know About The Treatment Of Mycobacterium Tuberculosis
IDStewardship
JUNE 19, 2025
Despite advancements in treatment, certain patients may exhibit delayed responses, have drug-resistant TB, be at risk for drug-drug interactions, or have comorbid conditions that considerably complicate clinical management. Antimicrob Agents Chemother 2007; 51:3781–8. 6. Gumbo T, Louie A, Deziel MR, et al. Patel, A.M.
Let's personalize your content